Coerente Capital Management’s AbbVie ABBV Stock Holding History

Coerente Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Hold	4,200	–	–	0.19%	32
2026 Q1	$913K	Hold	4,200	–	–	0.17%	32
2025 Q4	$960K	Hold	4,200	–	–	0.18%	33
2025 Q3	$972K	Hold	4,200	–	–	0.17%	30
2025 Q2	$780K	Hold	4,200	–	–	0.14%	30
2025 Q1	$880K	Hold	4,200	–	–	0.17%	26
2024 Q4	$746K	Hold	4,200	–	–	0.14%	31
2024 Q3	$829K	Hold	4,200	–	–	0.15%	30
2024 Q2	$720K	Hold	4,200	–	–	0.14%	31
2024 Q1	$765K	Buy	4,200 +2,667	+174%	+$460K	0.14%	30
2023 Q4	$238K	Buy	+1,533	New	+$223K	0.05%	37

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Coerente Capital Management's ABBV Position: Q2 2026 in Review

Coerente Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 4,200 shares worth $1.06M. The position accounts for 0.19% of the portfolio, ranked #32.

Coerente Capital Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Coerente Capital Management held 4,200 shares of AbbVie worth $1.06M as of Q2 2026.
Coerente Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.19% of Coerente Capital Management's portfolio in Q2 2026, its #32 holding.
Coerente Capital Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Coerente Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.